No. 33330 (5-year Review): Rule R590-132. Insurance Treatment of Human Immunodeficiency Virus (HIV) Infection  

  • DAR File No.: 33330
    Filed: 01/19/2010 11:44:30 AM

    NOTICE OF REVIEW AND STATEMENT OF CONTINUATION

    Concise explanation of the particular statutory provisions under which the rule is enacted and how these provisions authorize or require the rule:

    Subsections 31A-2-201(3) and (4) authorize the commissioner to write rules to implement the code. The rule identifies and restricts certain underwriting, classification, or declination practices that have been used to discriminate against individuals with HIV infection. The rule also provides guidelines regarding confidentiality of AIDS-related testing.

    Summary of written comments received during and since the last five-year review of the rule from interested persons supporting or opposing the rule:

    The department has not received any written comments regarding this rule in the past five years.

    Reasoned justification for continuation of the rule, including reasons why the agency disagrees with comments in opposition to the rule, if any:

    This rule makes sure that persons with HIV infection will not be singled out for either unfair discrimination or preferential treatment for insurance purposes. The rule also sets guidelines for HIV testing and use of test results to protect consumers and their information. Therefore, this rule should be continued.

    The full text of this rule may be inspected, during regular business hours, at the Division of Administrative Rules, or at:

    Insurance
    Administration
    450 N MAIN ST
    SALT LAKE CITY, UT 84114-1201

    Direct questions regarding this rule to:

    Effective:

    01/19/2010

    Authorized by:

    Jilene Whitby, Information Specialist


Document Information

Effective Date:
1/19/2010
Publication Date:
02/15/2010
Filed Date:
01/19/2010
Agencies:
Insurance,Administration
Authorized By:
Jilene Whitby, Information Specialist
DAR File No.:
33330
Related Chapter/Rule NO.: (1)
R590-132. Insurance Treatment of Human Immunodeficiency Virus (HIV) Infection.